Companies and Brands
Altria's Diversification Into Vaping and Cannabis May Have Too High a Cost
Published:
Last Updated:
Diversification is supposed to be a good thing. At what price is another issue entirely. When Altria Group Inc. (NYSE: MO) decided to expand its efforts into cannabis and vaping, the measures may have come at too much of a cost.
Altria stock was lower on Thursday after the news of a $12.8 billion investment into the Juul vaping company. That makes a tally of $14.6 billion spent, if you include the $1.8 billion into Canadian cannabis company Cronos Group Inc. (NYSE: CRON).
Credit ratings agencies have issued two different ratings actions on the heels of this larger transaction. One was an outright downgrade and one was a change in the outlook.
Standard & Poor’s has lowered Altria’s credit rating by two notches to BBB from A− in the call. S&P also said its outlook is now stable. This was after the $12.8 billion investment in e-cigarette maker Juul and its prior $1.8 billion investment in Cronos. S&P doesn’t believe that either investment will bring any significant returns in the near term. And with Altria’s high shareholder returns, S&P also does not expect any meaningful deleveraging over the next few years.
Also worth noting was that S&P sees a growing uncertainty over how the FDA and state regulators could affect the tobacco and non-tobacco products
Moody’s has maintained Altria’s A3 long-term credit rating but revised its outlook to negative from stable. Moody’s maintains that Altria still has strong earnings and cash flow and these investments now likely mean that the company will not need to make any significant debt-funded investments in the next few years.
Altria’s shares were last seen trading down 2.5% at $50.12, which is down almost 33% from its highs of 2018, and its shares hit a new 52-week low on Thursday. Altria now has a 52-week trading range of $49.29 to $72.95. Its market cap is roughly $94 billion, and its dividend yield is currently 6.4% with its shares down this low.
Sometimes diversification just comes at too high of a price. That said, many investors have shied away from the future of smoking cigarettes.
Are You Still Paying With a Debit Card?
The average American spends $17,274 on debit cards a year, and it’s a HUGE mistake. First, debit cards don’t have the same fraud protections as credit cards. Once your money is gone, it’s gone. But more importantly you can actually get something back from this spending every time you swipe.
Issuers are handing out wild bonuses right now. With some you can earn up to 5% back on every purchase. That’s like getting a 5% discount on everything you buy!
Our top pick is kind of hard to imagine. Not only does it pay up to 5% back, it also includes a $200 cash back reward in the first six months, a 0% intro APR, and…. $0 annual fee. It’s quite literally free money for any one that uses a card regularly. Click here to learn more!
Flywheel Publishing has partnered with CardRatings to provide coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.